The timing of this year’s Veterinary Symposium could not be better. It coincides with the launch of the proposed new legislative framework for veterinary medicines in the EU. Delegates will find out first hand from the Commission what the proposals will be, how the role of the EMA will change and the likely impact on both the national regulators and those who are regulated. This major rationalisation of all the existing legislation will streamline the workload of everyone involved in bringing new veterinary medicines to market. It will shape the work of veterinary regulatory affairs for the next 20 years. These developments should also be set against a backdrop of increasing globalisation and regulatory cooperation between the EU and the US - a great step forward as companies seek to gain global approval for new veterinary medicinal products.
